Author

Bram Verstockt

TARGET ENGAGEMENT AND PHARMACODYNAMIC MOLECULAR MECHANISM EVALUATION IN A PHASE 1B STUDY OF THE NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN, LEUCINE RICH REPEAT CONTAINING X1 (NLRX1) AGONIST NX-13 IN ULCERATIVE COLITIS
TARGET ENGAGEMENT AND PHARMACODYNAMIC MOLECULAR MECHANISM EVALUATION IN A PHASE 1B STUDY OF THE NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN, LEUCINE RICH REPEAT CONTAINING X1 (NLRX1) AGONIST NX-13 IN ULCERATIVE COLITIS

Bram Verstockt  et al.

USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE
USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE

Bram Verstockt  et al.

ENDOSCOPIC AND HISTOLOGIC REMISSION IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT
ENDOSCOPIC AND HISTOLOGIC REMISSION IN TOFACITINIB TREATED REFRACTORY MODERATE-TO-SEVERE PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-LIFE COHORT

Bram Verstockt  et al.

PREDICTING TOFACITINIB INDUCED ENDOSCOPIC RESPONSE IN ULCERATIVE COLITIS THROUGH A MUCOSAL BIOMARKER
PREDICTING TOFACITINIB INDUCED ENDOSCOPIC RESPONSE IN ULCERATIVE COLITIS THROUGH A MUCOSAL BIOMARKER

Bram Verstockt  et al.

USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE
USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE

Modulation of S1P receptors: Towards the real mechanism
Modulation of S1P receptors: Towards the real mechanism

Bram Verstockt

Precision medicine in UC: Unicorn or pangolin?
Precision medicine in UC: Unicorn or pangolin?

Bram Verstockt

EXPOSURE TO AN INFLAMMATORY MIX RE-INDUCES INFLAMMATION IN ORGANOIDS OF ULCERATIVE COLITIS PATIENTS, INDEPENDENT OF THE INFLAMMATORY STATE OF THE TISSUE OF ORIGIN
EXPOSURE TO AN INFLAMMATORY MIX RE-INDUCES INFLAMMATION IN ORGANOIDS OF ULCERATIVE COLITIS PATIENTS, INDEPENDENT OF THE INFLAMMATORY STATE OF THE TISSUE OF ORIGIN

Bram Verstockt  et al.

MECHANISMS OF NON-RESPONSE TO ADALIMUMAB IN INFLAMMATORY BOWEL DISEASE: PERIPHERAL PROTEOMIC AND TRANSCRIPTOMIC PROFILING FROM THE SERENE-CD AND SERENE-UC STUDIES
MECHANISMS OF NON-RESPONSE TO ADALIMUMAB IN INFLAMMATORY BOWEL DISEASE: PERIPHERAL PROTEOMIC AND TRANSCRIPTOMIC PROFILING FROM THE SERENE-CD AND SERENE-UC STUDIES

Bram Verstockt  et al.

INTESTINAL EXPRESSION OF THE SARS-COV-2 RECEPTOR ACE2 AND TMPRSS2 IN BIOPSIES AND DERIVED ORGANOIDS FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE
INTESTINAL EXPRESSION OF THE SARS-COV-2 RECEPTOR ACE2 AND TMPRSS2 IN BIOPSIES AND DERIVED ORGANOIDS FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Bram Verstockt  et al.

EXPERT CONSENSUS TO STANDARDISE TRANSCRIPTOME ANALYSIS IN INFLAMMATORY BOWEL DISEASE CLINICAL TRIALS
EXPERT CONSENSUS TO STANDARDISE TRANSCRIPTOME ANALYSIS IN INFLAMMATORY BOWEL DISEASE CLINICAL TRIALS

Bram Verstockt  et al.

INFLAMMATORY BOWEL DISEASE: A PHENOME-WIDE PRE- AND POST-DIAGNOSTIC ASSOCIATION STUDY
INFLAMMATORY BOWEL DISEASE: A PHENOME-WIDE PRE- AND POST-DIAGNOSTIC ASSOCIATION STUDY

Bram Verstockt  et al.

MICROBIOME DYSBIOSIS, INTESTINAL EPITHELIAL CELL DYSFUNCTION AND IMMUNE SYSTEM DEREGULATION IN PATIENTS WITH CROHN'S DISEASE
MICROBIOME DYSBIOSIS, INTESTINAL EPITHELIAL CELL DYSFUNCTION AND IMMUNE SYSTEM DEREGULATION IN PATIENTS WITH CROHN'S DISEASE

Bram Verstockt  et al.

SCORING OF HISTOLOGICAL REMISSION IN ULCERATIVE COLITIS BASED ON AUTOMATED COMPUTER-AIDED ANALYSIS OF ENDOSCOPIC IMAGES OUTPERFORMS HUMAN SCORING
SCORING OF HISTOLOGICAL REMISSION IN ULCERATIVE COLITIS BASED ON AUTOMATED COMPUTER-AIDED ANALYSIS OF ENDOSCOPIC IMAGES OUTPERFORMS HUMAN SCORING

Bram Verstockt  et al.

IMPACT ON AEROSOL GENERATION OF A MOUTHPIECE DESIGNED TO REDUCE DROPLET SPREAD OF COVID-19 DURING UPPER GASTROINTESTINAL ENDOSCOPY, A SINGLE CENTER RANDOMIZED CONTROLLED TRIAL
IMPACT ON AEROSOL GENERATION OF A MOUTHPIECE DESIGNED TO REDUCE DROPLET SPREAD OF COVID-19 DURING UPPER GASTROINTESTINAL ENDOSCOPY, A SINGLE CENTER RANDOMIZED CONTROLLED TRIAL

Bram Verstockt  et al.

THE REAL-LIFE DIAGNOSTIC ACCURACY OF REGULAR ARRANGEMENT OF COLLECTING VENULES IN DETECTING H.PYLORI-NEGATIVE PATIENTS
THE REAL-LIFE DIAGNOSTIC ACCURACY OF REGULAR ARRANGEMENT OF COLLECTING VENULES IN DETECTING H.PYLORI-NEGATIVE PATIENTS

Bram Verstockt  et al.

DISEASE ACCEPTANCE, BUT NOT PERCEIVED CONTROL, IS UNIQUELY ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE-RELATED DISABILITY
DISEASE ACCEPTANCE, BUT NOT PERCEIVED CONTROL, IS UNIQUELY ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE-RELATED DISABILITY

Bram Verstockt  et al.

ASSOCIATION OF BASELINE IL-23 PATHWAY-ASSOCIATED GENE EXPRESSION WITH RISANKIZUMAB-INDUCED CLINICAL REMISSION AND ENDOSCOPIC RESPONSE AT WEEK 12 IN CROHN’S DISEASE PATIENTS
ASSOCIATION OF BASELINE IL-23 PATHWAY-ASSOCIATED GENE EXPRESSION WITH RISANKIZUMAB-INDUCED CLINICAL REMISSION AND ENDOSCOPIC RESPONSE AT WEEK 12 IN CROHN’S DISEASE PATIENTS

Bram Verstockt  et al.

EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY FOR CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS
EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY FOR CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS

Bram Verstockt  et al.

AN AUTOMATED SYSTEM FOR ESTIMATION OF HISTOLOGICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS: COMPARISON OF PERFORMANCES WITH WHITE LIGHT VERSUS SINGLE WAVELENGTH ENDOSCOPY
AN AUTOMATED SYSTEM FOR ESTIMATION OF HISTOLOGICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS: COMPARISON OF PERFORMANCES WITH WHITE LIGHT VERSUS SINGLE WAVELENGTH ENDOSCOPY

Bram Verstockt  et al.

Item 1 - 20 / 26
1
2